NRBO
Price:
$2.36
Market Cap:
$20.33M
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2016-08-05
Stock Exchange
NASDAQ
Ticker
NRBO
According to NeuroBo Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -1181216.00. This represents a change of -151.51% compared to the average of 2.29M of the last 4 quarters.
The mean historical Enterprise Value of NeuroBo Pharmaceuticals, Inc. over the last ten years is 253.50M. The current -1181216.00 Enterprise Value has changed -146.60% with respect to the historical average. Over the past ten years (40 quarters), NRBO's Enterprise Value was at its highest in in the March 2020 quarter at 1.73B. The Enterprise Value was at its lowest in in the December 2022 quarter at -15113658.52.
Average
253.50M
Median
207.72M
Minimum
-31517424.78
Maximum
679.19M
Discovering the peaks and valleys of NeuroBo Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 135.43%
Maximum Annual Enterprise Value = 679.19M
Minimum Annual Increase = -364.42%
Minimum Annual Enterprise Value = -31517424.78
Year | Enterprise Value | Change |
---|---|---|
2023 | -3476700.00 | -88.97% |
2022 | -31517424.78 | -364.42% |
2021 | 11.92M | -84.14% |
2020 | 75.15M | 135.43% |
2019 | 31.92M | -95.30% |
2018 | 679.19M | 4.82% |
2017 | 647.96M | 90.41% |
2016 | 340.29M | -13.40% |
2015 | 392.96M | 0.61% |
The current Enterprise Value of NeuroBo Pharmaceuticals, Inc. (NRBO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-7691611.73
5-year avg
16.80M
10-year avg
253.50M
NeuroBo Pharmaceuticals, Inc.’s Enterprise Value is greater than Allarity Therapeutics, Inc. (-12736306.00), less than Hillstream BioPharma, Inc. (1.48M), less than Virax Biolabs Group Limited (4.23M), less than Quoin Pharmaceuticals, Ltd. (-243459.00), less than Kiromic BioPharma, Inc. (13.21M), less than Biodexa Pharmaceuticals Plc (735.77M), greater than Zura Bio Limited (-39351752.00), greater than Phio Pharmaceuticals Corp. (-3532813.00), less than Sonnet BioTherapeutics Holdings, Inc. (4.67M), less than 180 Life Sciences Corp. (3.96M), less than Cardio Diagnostics Holdings, Inc. (38.12M), less than Blue Water Vaccines, Inc. (12.54M), less than PaxMedica, Inc. Common Stock (524.09K), greater than Revelation Biosciences, Inc. (-4075884.00), less than Kiora Pharmaceuticals, Inc. (4.25M),
Company | Enterprise Value | Market cap |
---|---|---|
-12736306.00 | $4.39M | |
1.48M | $4.17M | |
4.23M | $7.60M | |
-243459.00 | $2.87M | |
13.21M | $1.42M | |
735.77M | $927.02M | |
-39351752.00 | $148.87M | |
-3532813.00 | $1.86M | |
4.67M | $4.69M | |
3.96M | $3.68M | |
38.12M | $39.38M | |
12.54M | $3.41M | |
524.09K | $848.58K | |
-4075884.00 | $2.47M | |
4.25M | $9.81M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroBo Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeuroBo Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is NeuroBo Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for NeuroBo Pharmaceuticals, Inc. (NRBO)?
What is the 3-year average Enterprise Value for NeuroBo Pharmaceuticals, Inc. (NRBO)?
What is the 5-year average Enterprise Value for NeuroBo Pharmaceuticals, Inc. (NRBO)?
How does the current Enterprise Value for NeuroBo Pharmaceuticals, Inc. (NRBO) compare to its historical average?